Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for postoperative gastrointestinal recovery after total knee arthroplasty in elderly patients
ChiCTR2600135857Phase 4Not yet recruiting
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in knee osteoarthritis (OA) (2 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoint: Time to first postoperative flatus or bowel movement. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2600135857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135857.